$CYAN
CYANOTECH CORP

2019 Q3 Form 10-Q Financial Statement

#000143774919022447 Filed on November 12, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2018 Q3 2018 Q2
Revenue $7.690M $6.954M $7.145M
YoY Change 10.58% -13.67% -18.89%
Cost Of Revenue $4.627M $4.669M $5.309M
YoY Change -0.9% 5.28% 1.98%
Gross Profit $3.063M $2.285M $1.836M
YoY Change 34.05% -36.88% -49.04%
Gross Profit Margin 39.83% 32.86% 25.7%
Selling, General & Admin $2.500M $3.078M $2.795M
YoY Change -18.78% 7.92% -1.62%
% of Gross Profit 81.62% 134.7% 152.23%
Research & Development $154.0K $211.0K $208.0K
YoY Change -27.01% 41.61% 46.48%
% of Gross Profit 5.03% 9.23% 11.33%
Depreciation & Amortization $480.0K $475.0K $475.0K
YoY Change 1.05% 3.26% -0.84%
% of Gross Profit 15.67% 20.79% 25.87%
Operating Expenses $2.654M $3.289M $3.003M
YoY Change -19.31% 9.6% 0.67%
Operating Profit $409.0K -$1.004M -$1.167M
YoY Change -140.74% -262.2% -288.23%
Interest Expense $182.0K $150.0K $130.0K
YoY Change 21.33% -212.78% -220.37%
% of Operating Profit 44.5%
Other Income/Expense, Net
YoY Change
Pretax Income $227.0K -$1.154M -$1.297M
YoY Change -119.67% -337.45% -353.32%
Income Tax -$1.000K -$18.00K -$22.00K
% Of Pretax Income -0.44%
Net Earnings $228.0K -$1.136M -$1.275M
YoY Change -120.07% -339.16% -354.49%
Net Earnings / Revenue 2.96% -16.34% -17.84%
Basic Earnings Per Share $0.04 -$0.20 -$0.22
Diluted Earnings Per Share $0.04 -$0.20 -$0.22
COMMON SHARES
Basic Shares Outstanding 5.965M 5.806M 5.785M
Diluted Shares Outstanding 5.973M 5.806M 5.785M

Balance Sheet

Concept 2019 Q3 2018 Q3 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.090M $660.0K $940.0K
YoY Change 65.15% -68.57% -27.69%
Cash & Equivalents $1.094M $663.0K $935.0K
Short-Term Investments
Other Short-Term Assets $450.0K $700.0K $590.0K
YoY Change -35.71% 55.56% 37.21%
Inventory $11.13M $10.44M $9.487M
Prepaid Expenses
Receivables $1.655M $1.882M $2.804M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.33M $13.68M $13.82M
YoY Change 4.69% 2.08% 12.11%
LONG-TERM ASSETS
Property, Plant & Equipment $13.87M $15.12M $15.43M
YoY Change -8.3% -5.62% -5.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $261.0K $298.0K $280.0K
YoY Change -12.42% 18.73% 35.27%
Total Long-Term Assets $18.11M $15.42M $15.71M
YoY Change 17.45% -5.25% -4.75%
TOTAL ASSETS
Total Short-Term Assets $14.33M $13.68M $13.82M
Total Long-Term Assets $18.11M $15.42M $15.71M
Total Assets $32.44M $29.10M $29.53M
YoY Change 11.45% -1.94% 2.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.838M $4.295M $3.735M
YoY Change -33.92% 23.67% 19.25%
Accrued Expenses $834.0K $811.0K $1.000M
YoY Change 2.84% -19.86% -12.51%
Deferred Revenue $304.0K
YoY Change
Short-Term Debt $2.050M $1.750M $1.250M
YoY Change 17.14% 250.0% 150.0%
Long-Term Debt Due $2.673M $660.0K $660.0K
YoY Change 305.0% 4.76% 6.45%
Total Short-Term Liabilities $7.007M $7.602M $6.945M
YoY Change -7.83% 33.77% 26.76%
LONG-TERM LIABILITIES
Long-Term Debt $6.349M $5.480M $5.640M
YoY Change 15.86% -8.05% -7.69%
Other Long-Term Liabilities $58.00K $90.00K $100.0K
YoY Change -35.56% -18.18% 0.0%
Total Long-Term Liabilities $6.407M $5.570M $5.740M
YoY Change 15.03% -8.24% -7.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.007M $7.602M $6.945M
Total Long-Term Liabilities $6.407M $5.570M $5.740M
Total Liabilities $17.09M $13.18M $12.68M
YoY Change 29.72% 12.13% 8.53%
SHAREHOLDERS EQUITY
Retained Earnings -$17.56M -$16.47M -$15.33M
YoY Change 6.62% 16.75% 5.15%
Common Stock $118.0K $117.0K $116.0K
YoY Change 0.85% 1.74% 1.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.34M $15.93M $16.85M
YoY Change
Total Liabilities & Shareholders Equity $32.44M $29.10M $29.53M
YoY Change 11.45% -1.94% 2.46%

Cashflow Statement

Concept 2019 Q3 2018 Q3 2018 Q2
OPERATING ACTIVITIES
Net Income $228.0K -$1.136M -$1.275M
YoY Change -120.07% -339.16% -354.49%
Depreciation, Depletion And Amortization $480.0K $475.0K $475.0K
YoY Change 1.05% 3.26% -0.84%
Cash From Operating Activities $290.0K -$440.0K -$865.0K
YoY Change -165.91% -137.29% -511.9%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K -$170.0K -$170.0K
YoY Change -76.47% -22.73% 183.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$40.00K -$170.0K -$173.0K
YoY Change -76.47% -22.73% 208.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $141.0K
YoY Change 8.46%
Cash From Financing Activities -220.0K 340.0K 579.0K
YoY Change -164.71% -312.5% -320.99%
NET CHANGE
Cash From Operating Activities 290.0K -440.0K -865.0K
Cash From Investing Activities -40.00K -170.0K -173.0K
Cash From Financing Activities -220.0K 340.0K 579.0K
Net Change In Cash 30.00K -270.0K -459.0K
YoY Change -111.11% -133.75% 325.0%
FREE CASH FLOW
Cash From Operating Activities $290.0K -$440.0K -$865.0K
Capital Expenditures -$40.00K -$170.0K -$170.0K
Free Cash Flow $330.0K -$270.0K -$695.0K
YoY Change -222.22% -119.29% -357.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
338000
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20216000
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19254000
CY2018Q3 cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
16000
cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
100000
CY2018Q3 cyan Stock Issued During Period Value Director Stockgrants
StockIssuedDuringPeriodValueDirectorStockgrants
170000
cyan Stock Issued During Period Value Director Stockgrants
StockIssuedDuringPeriodValueDirectorStockgrants
170000
CY2019Q3 cyan Working Capital Deficit
WorkingCapitalDeficit
7319000
CY2019Q1 cyan Working Capital Deficit
WorkingCapitalDeficit
5104000
cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
141000
CY2019Q3 cyan Number Of Shareholder Approved Sharebased Compensation Plans
NumberOfShareholderApprovedSharebasedCompensationPlans
2
cyan Operating Lease Rightofuse Asset Amortization
OperatingLeaseRightofuseAssetAmortization
144000
cyan Operating Lease Rightofuse Asset Amortization
OperatingLeaseRightofuseAssetAmortization
cyan Repayments Of Short Term Contractual Obligation
RepaymentsOfShortTermContractualObligation
231000
cyan Repayments Of Short Term Contractual Obligation
RepaymentsOfShortTermContractualObligation
CY2019Q3 cyan Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
83000
CY2019Q1 cyan Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
235000
CY2019Q3 cyan Adjustments To Additional Paid In Capital Settlement Agreement With A Former Executive
AdjustmentsToAdditionalPaidInCapitalSettlementAgreementWithAFormerExecutive
-1000
cyan Adjustments To Additional Paid In Capital Settlement Agreement With A Former Executive
AdjustmentsToAdditionalPaidInCapitalSettlementAgreementWithAFormerExecutive
320000
cyan Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-144000
cyan Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
CY2018Q3 cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
0
cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
250000
cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
0
CY2019Q3 cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
0
CY2019Q3 cyan Longterm Debt Current Maturities Excluding Line Of Credit Current
LongtermDebtCurrentMaturitiesExcludingLineOfCreditCurrent
673000
CY2019Q1 cyan Longterm Debt Current Maturities Excluding Line Of Credit Current
LongtermDebtCurrentMaturitiesExcludingLineOfCreditCurrent
663000
CY2019Q3 cyan Longterm Debt Gross Excluding Current Maturities
LongtermDebtGrossExcludingCurrentMaturities
6533000
CY2019Q1 cyan Longterm Debt Gross Excluding Current Maturities
LongtermDebtGrossExcludingCurrentMaturities
5372000
CY2019Q3 cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
85000
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2838000
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4922000
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1655000
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1982000
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
834000
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
992000
CY2019Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
206000
CY2019Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
145000
CY2019Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
274000
us-gaap Share Based Compensation
ShareBasedCompensation
244000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
582104
CY2019Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6483000
CY2019Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6587000
CY2019Q3 us-gaap Inventory Net
InventoryNet
11129000
CY2019Q1 us-gaap Inventory Net
InventoryNet
11274000
dei Entity Registrant Name
EntityRegistrantName
Cyanotech Corp
dei Entity Central Index Key
EntityCentralIndexKey
0000768408
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Type
DocumentType
10-Q
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5917511
dei Amendment Flag
AmendmentFlag
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
117000
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32786000
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32447000
CY2019Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
41000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
41000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
74000
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13000
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
27000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
34000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
39000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019Q3 us-gaap Assets
Assets
32437000
CY2019Q1 us-gaap Assets
Assets
29626000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
14326000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
14592000
CY2019Q1 us-gaap Cash
Cash
940000
CY2018Q1 us-gaap Cash
Cash
1329000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1094000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
840000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
840000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1394000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1094000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
663000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
254000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-731000
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5913421
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5879710
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5913421
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5879710
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
118000
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
304000
CY2019Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
626000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;">Concentration Risk</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:29.4pt;margin-right:21.9pt;margin-top:0pt;text-align:left;text-indent:28.5pt;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 36pt;">A significant portion of revenue and accounts receivable are derived from a few major customers. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"></div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> </div>customers accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17%,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14%,</div> respectively, of the Company&#x2019;s net sales. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"></div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> </div>customers accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">34%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%,</div> respectively, of the Company&#x2019;s net sales. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2019, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"></div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> </div>customers accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">67%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60%,</div> respectively, of the Company&#x2019;s accounts receivable balance.</div></div></div></div></div></div></div></div></div></div>
CY2019Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
222000
CY2019Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
256000
CY2019Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6000
CY2018Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
517000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
114000
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4627000
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4669000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9023000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9978000
CY2019Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
184000
CY2019Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
200000
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
480000
CY2018Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
475000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
971000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
950000
CY2019Q3 us-gaap Dilutive Securities
DilutiveSecurities
us-gaap Dilutive Securities
DilutiveSecurities
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.002
CY2018Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.016
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.038
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.016
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-145000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
768000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-327000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-782000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-158000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-81000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-322000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-50000
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
1000
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-10000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
32000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
33000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1157000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1481000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3188000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2853000
CY2019Q3 us-gaap Gross Profit
GrossProfit
3063000
CY2018Q3 us-gaap Gross Profit
GrossProfit
2285000
us-gaap Gross Profit
GrossProfit
6738000
us-gaap Gross Profit
GrossProfit
4121000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
227000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1154000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
91000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2451000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-18000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-40000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-40000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2084000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1405000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-51000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
139000
CY2019Q3 us-gaap Interest Expense
InterestExpense
182000
CY2018Q3 us-gaap Interest Expense
InterestExpense
150000
us-gaap Interest Expense
InterestExpense
367000
us-gaap Interest Expense
InterestExpense
280000
us-gaap Interest Paid Net
InterestPaidNet
337000
us-gaap Interest Paid Net
InterestPaidNet
219000
CY2019Q1 us-gaap Long Term Debt
LongTermDebt
126000
CY2019Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
228000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29626000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7007000
CY2019Q3 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
7206000
CY2019Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive
3245000
CY2019Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
279000
CY2019Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
468000
CY2019Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
331000
CY2019Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
495000
CY2019Q3 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
211000
CY2019Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
160000
CY2019Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4104000
CY2019Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4032000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6453000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3878000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
371000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
426000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
592000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
595000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
591000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2470000
CY2019Q3 us-gaap Liabilities
Liabilities
17093000
CY2019Q1 us-gaap Liabilities
Liabilities
14717000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32437000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9488000
CY2016Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2000000
CY2019Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2000000
CY2019Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2000000
CY2019Q3 us-gaap Long Term Debt
LongTermDebt
110000
CY2019Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
2202000
CY2019Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
676000
CY2019Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
336000
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2673000
CY2019Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2663000
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6349000
CY2019Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5172000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
919000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
920000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-86000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-338000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-579000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1313000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
228000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-1136000
us-gaap Net Income Loss
NetIncomeLoss
95000
us-gaap Net Income Loss
NetIncomeLoss
-2411000
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
95000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
2654000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
3289000
us-gaap Operating Expenses
OperatingExpenses
6280000
us-gaap Operating Expenses
OperatingExpenses
6292000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
409000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1004000
us-gaap Operating Income Loss
OperatingIncomeLoss
458000
us-gaap Operating Income Loss
OperatingIncomeLoss
-2171000
us-gaap Operating Lease Cost
OperatingLeaseCost
296000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3983000
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
304000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3679000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3983000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.075
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P13Y182D
CY2019Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
130000
CY2019Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
121000
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
261000
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
282000
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
58000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
57000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
25000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
32000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
86000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
338000
CY2019Q3 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
141000
CY2019Q1 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
153000
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
448000
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
496000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1500000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1250000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19000
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33861000
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33750000
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13867000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14752000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
297000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
284000
CY2015Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
500000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
154000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
211000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
341000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
419000
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
65000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17560000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17655000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7690000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6954000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15761000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14099000
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1343000
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1597000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2751000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3020000
us-gaap Share Based Compensation
ShareBasedCompensation
361000
CY2018Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.52
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y255D
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1650000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1252335
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
405800
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.14
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
81888
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15480
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
539800
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
455800
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.06
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.01
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.08
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.41
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2019Q3 us-gaap Share Price
SharePrice
2.59
CY2019Q1 us-gaap Share Price
SharePrice
3.24
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y255D
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
130000
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
50000
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.70
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y182D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
80000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.81
CY2019Q3 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
54000
CY2019Q1 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
285000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2112
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-7000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-25000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-32000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
15344000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
14909000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
15104000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
16852000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
15927000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
18107000
CY2019Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 21.9pt;text-align:left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 36pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of any contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods reported.&nbsp; Management reviews these estimates and assumptions periodically and reflects the effect of revisions in the period that they are determined to be necessary.&nbsp; Actual results could differ from those estimates and assumptions.</div></div></div></div></div></div></div></div></div></div>
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
8000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
21000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5973000
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5806000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5963000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5796000
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5806000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5796000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5965000
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5806000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5942000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5796000

Files In Submission

Name View Source Status
0001437749-19-022447-index-headers.html Edgar Link pending
0001437749-19-022447-index.html Edgar Link pending
0001437749-19-022447.txt Edgar Link pending
0001437749-19-022447-xbrl.zip Edgar Link pending
cyan-20190930.xml Edgar Link completed
cyan-20190930.xsd Edgar Link pending
cyan-20190930_cal.xml Edgar Link unprocessable
cyan-20190930_def.xml Edgar Link unprocessable
cyan-20190930_lab.xml Edgar Link unprocessable
cyan-20190930_pre.xml Edgar Link unprocessable
cyan20190930_10q.htm Edgar Link pending
ex_162770.htm Edgar Link pending
ex_162771.htm Edgar Link pending
ex_162772.htm Edgar Link pending
ex_162773.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
logo1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending